Lotus Ventures Inc.

J

CA54571Q1081

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 10:07:16 28/03/2024 pm IST			5-day change	1st Jan Change
0.01 ^CAD	-.--%		-.--%	-33.33%

2023	Lotus Ventures Inc. Launches Joker Juice Cannabis Strain in BC	CI
2023	Lotus Ventures Inc. Reports Earnings Results for the Nine Months Ended May 31, 2023	CI

Lotus Ventures Inc. Reports Earnings Results for the First Quarter Ended November 30, 2018

January 31, 2019 at 01:03 am IST

Lotus Ventures Inc. announced earnings results for the first quarter ended November 30, 2018. For the first quarter, the company announced net loss was CAD 839,264 compared to CAD 683,618 a year ago. Basic loss per share was CAD 0.01 compared to CAD 0.02 a year ago.

Latest news about Lotus Ventures Inc.

Lotus Ventures Inc. Launches Joker Juice Cannabis Strain in BC	16/12	CI
Lotus Ventures Inc. Reports Earnings Results for the Nine Months Ended May 31, 2023	03/23/03	CI
Lotus Ventures Inc. Reports Earnings Results for the Half Year Ended February 28, 2023	01/23/01	CI
Lotus Launches Keylime Kush Flower in Ontario Under the Lotus Cannabis Co. Brand	11/23/11	CI
Lotus Ventures Inc. Shares Update on Keylime Kush Sales in British Columbia	10/23/10	MT
Lotus Ventures Inc. Updates on Its Initial Sales Results from the Launch of Its Keylime Kush Flower and Pre-Rolls in British Columbia	10/23/10	CI
Lotus Ventures Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	01/23/01	CI
Lotus Ventures Inc. Auditor Raises 'Going Concern' Doubt	22/23/22	CI
Lotus Ventures Inc. Reports Earnings Results for the Full Year Ended August 31, 2022	22/23/22	CI
Lotus Launches First Keylime Kush Cultivar Under the Lotus Cannabis Co. Brand in British Columbia	23/23/23	CI
Lotus Ventures Inc. Appoints Albert Duwyn as New Chairman of the Board of Directors	07/22/07	CI
Earnings Flash (LTTSF) LOTUS VENTURES Posts Q3 EPS $0.00	03/22/03	MT
Lotus Ventures Inc. Reports Earnings Results for the Nine Months Ended May 31, 2022	02/22/02	CI
Lotus Ventures Inc. Reports Earnings Results for the Half Year Ended February 28, 2022	30/22/30	CI
Lotus Ventures Inc. Announces Second Official Collaborative Strain Launch with Auxly Cannabis Group Inc	21/22/21	CI
Lotus Ventures Inc. Reports Earnings Results for the First Quarter Ended November 30, 2021	31/22/31	CI
Lotus Ventures Inc. Auditor Raises 'Going Concern' Doubt	29/21/29	CI
Lotus Ventures Inc. Reports Earnings Results for the Full Year Ended August 31, 2021	29/21/29	CI
Lotus Ventures Inc. Accelerates Path to Retail Market Sales Upon Receipt of Standard Processing Licence from Health Canada	08/21/08	CI
Lotus Ventures Inc. Provides Earnings Guidance for the Fifth Quarter of 2022 and Fourth Quarter Ended August 2021	08/21/08	CI
Lotus Ventures Inc. Reports Earnings Results for the Third Quarter Ended May 31, 2021	31/21/31	CI
Lotus Ventures Inc. Reports Earnings Results for the Second Quarter Ended February 28, 2021	29/21/29	CI
Lotus Ventures Inc. Announces Changes to Its Board	16/21/16	CI
Lotus Ventures Inc. Reports Revenue Results for the First Quarter Ended January 31, 2021	01/21/01	CI
Lotus Ventures Inc. Reports Earnings Results for the First Quarter Ended November 30, 2020	30/21/30	CI

Chart Lotus Ventures Inc.

Duration

Period

More charts

Company Profile

Lotus Ventures Inc. is a Canada-based licensed cannabis producer and owner of the Lotus Cannabis Co. brand. The Company primarily cultivates cannabis flowers, which are sold in the wholesale, recreational, and medical markets across Canada. The Company owns and operates a 22,500 square foot indoor cannabis production facility in Armstrong, British Columbia and holds the licenses for cultivation and sale of cannabis in Canada. It has grown several cultivars, including the Keylime Kush, Black Blossom, Tranquil Elephantizer, and Kalifornia. Its Keylime Kush recreational portfolio includes 3.5 gram flower, 14 gram flower, and 3 x 0.5 gram pre-rolls. The Company sells its flagship product, the Keylime Kush, to over 300 retail stores across British Columbia and Ontario.

Sector

Pharmaceuticals

Calendar

31/07/2024 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
LOTUS VENTURES INC.	-33.33%	845K
DONG-E-E-JIAO CO.,LTD.	+22.67%	5.41B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-35.93%	3.52B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-6.69%	2.96B
TASLY PHARMACEUTICAL GROUP CO., LTD	-27.73%	2.6B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-11.46%	2.29B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+38.57%	1.89B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+38.46%	1.47B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-16.41%	1.43B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+42.86%	1.36B